Merck & Co. (MRK)
(Delayed Data from NYSE)
$125.26 USD
-0.59 (-0.47%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $125.26 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 241 - 260 ( 398 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R